Axsome Therapeutics, Inc. (AXSM) Cash Flow Annual - Discounting Cash Flows
AXSM
Axsome Therapeutics, Inc.
AXSM (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
Report Filing: 2026-02-23 2026-02-23 2025-02-18 2024-02-23 2023-02-28 2022-03-01 2021-03-01 2020-03-12 2019-03-15 2018-03-07 2017-03-07 2016-03-24 2014-12-31 2013-12-31
Net Income/Starting Line -183.2 -183.2 -287.2 -239.2 -187.1 -130.4 -102.9 -68.35 -30.97 -28.94 -27.2 -10.56 -6 -2.17
Cash From Operating Activities -93.41 -93.41 -128.4 -145.1 -116.5 -108.2 -78.46 -46.38 -30.05 -26.47 -21.28 -7.44 -4.6 -1.63
Depreciation and Amortization 8.12 9.06 7.96 6.83 4.4 0.076 0.078 0.037 0.049 0.043 0.02 0.004 0 0
Deferred Income Tax 0 0 0 0 0 0 1.25 0 -2.79 0.646 0 2.28 0 0
Stock Based Compensation 71.02 0 0 62.62 37.73 20.8 14.76 6.12 1.75 2.07 2.03 0.803 0.377 0.055
Other Non-Cash Items 33.69 103.8 116.9 53.1 4.83 0.974 7.95 0.65 0.376 0.471 0.069 -0.902 0.513 0.327
Changes in Working Capital -23.06 -23.06 33.9 -28.39 23.67 0.324 0.412 15.17 1.52 -0.76 3.8 0.938 0.515 0.153
Accounts Receivable -82.46 -82.46 -47.18 -57.12 -37.7 0 0.177 0 0 0 0 0 0 0
Inventory -10.66 -10.66 0.744 -8.16 -5.28 -0.006 -0.177 0 0 0 0 0 0 0
Accounts Payable -6.46 -6.46 31.32 2.07 25.46 -0.355 2.56 7.26 0.252 -0.646 2.19 1.13 0.599 0.158
Deferred Revenue 76.53 76.53 49.02 34.81 41.19 0.685 -2.15 7.91 1.27 -0.114 1.61 -0.196 -0.084 -0.005
Other Working Capital 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cash From Investing Activities -0.48 -0.48 -0.27 -0.582 -53.7 -0.308 -0.046 -0.016 -0.033 -0.01 -0.105 -0.02 0 0
Investments in Property Plant and Equipment -0.48 -0.48 -0.27 -0.582 -0.702 -0.308 -0.046 -0.016 -0.033 -0.01 -0.105 -0.02 0 0
Payments for Acquisitions 0 0 0 0 -53 0 0 0 0 0 0 0 0 0
Purchases of Securities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales and Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cash From Financing Activities 101.5 101.5 57.84 331 284.6 11.13 42.41 252.4 10.03 23.88 9.97 52.88 5.13 3.72
Debt Repayment -7.75 -7.75 -0.99 85 45 0 28.34 12.76 -3.33 -0.278 10 7.34 5.19 3.78
Common Stock Issued 109.6 126.3 40.78 258.8 243.8 7.44 14.13 238.2 12.88 23.68 0.033 45.55 0 0
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities -0.408 -17.05 18.05 -12.74 -4.18 3.69 -0.053 1.39 0.486 0.485 -0.065 -0.012 -0.063 -0.058
Effect of Forex Changes on Cash 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Change in Cash 22.02 7.58 -70.84 185.4 114.4 -97.4 -36.09 206 -20.05 -2.6 -11.42 45.42 0.53 2.09
Cash at Beginning of Period 300.9 315.4 386.2 200.8 86.47 183.9 220 13.97 34.02 36.62 48.04 2.62 2.09 0.002
Cash at End of Period 322.9 322.9 315.4 386.2 200.8 86.47 183.9 220 13.97 34.02 36.62 48.04 2.62 2.09
Free Cash Flow -93.81 -93.41 -128.7 -145.7 -117.2 -108.5 -78.5 -46.39 -30.09 -26.48 -21.39 -7.46 -4.6 -1.63
Operating Cash Flow -93.41 -93.41 -128.4 -145.1 -116.5 -108.2 -78.46 -46.38 -30.05 -26.47 -21.28 -7.44 -4.6 -1.63
Capital Expenditure -0.409 0 -0.27 -0.582 -0.702 -0.308 -0.046 -0.016 -0.033 -0.01 -0.105 -0.02 0 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program